NEPH 📈 Nephros - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6406714005
NEPH: Ultrafiltration Products, Water Filters, Filtration Systems, Water Purifiers
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Web URL: https://www.nephros.com
Additional Sources for NEPH Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NEPH Stock Overview
Market Cap in USD | 17m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Household Appliances |
IPO / Inception | 2004-09-21 |
NEPH Stock Ratings
Growth 5y | -90.1% |
Fundamental | -18.1% |
Dividend | - |
Rel. Strength Industry | -270 |
Analysts | 4.5/5 |
Fair Price Momentum | 1.03 USD |
Fair Price DCF | 1.85 USD |
NEPH Dividends
No Dividends PaidNEPH Growth Ratios
Growth Correlation 3m | 7.7% |
Growth Correlation 12m | -91.6% |
Growth Correlation 5y | -71.3% |
CAGR 5y | -30.06% |
CAGR/Mean DD 5y | -0.52 |
Sharpe Ratio 12m | -1.25 |
Alpha | -70.59 |
Beta | 0.74 |
Volatility | 57.57% |
Current Volume | 8.8k |
Average Volume 20d | 9.8k |
What is the price of NEPH stocks?
As of December 21, 2024, the stock is trading at USD 1.54 with a total of 8,797 shares traded.
Over the past week, the price has changed by -0.65%, over one month by -3.14%, over three months by -16.30% and over the past year by -50.00%.
As of December 21, 2024, the stock is trading at USD 1.54 with a total of 8,797 shares traded.
Over the past week, the price has changed by -0.65%, over one month by -3.14%, over three months by -16.30% and over the past year by -50.00%.
Is Nephros a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Nephros is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -18.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEPH as of December 2024 is 1.03. This means that NEPH is currently overvalued and has a potential downside of -33.12%.
Neither. Based on ValueRay Fundamental Analyses, Nephros is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -18.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NEPH as of December 2024 is 1.03. This means that NEPH is currently overvalued and has a potential downside of -33.12%.
Is NEPH a buy, sell or hold?
Nephros has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy NEPH.
Nephros has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy NEPH.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for NEPH stock price target?
According to ValueRays Forecast Model, NEPH Nephros will be worth about 1.1 in December 2025. The stock is currently trading at 1.54. This means that the stock has a potential downside of -25.97%.
According to ValueRays Forecast Model, NEPH Nephros will be worth about 1.1 in December 2025. The stock is currently trading at 1.54. This means that the stock has a potential downside of -25.97%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 4.8 | 208.4% |
Analysts Target Price | 3 | 94.8% |
ValueRay Target Price | 1.1 | -26% |